Status:
COMPLETED
Evaluation Of Valaciclovir In Patients With Chickenpox
Lead Sponsor:
GlaxoSmithKline
Conditions:
Varicella
Eligibility:
All Genders
1-11 years
Phase:
PHASE3
Brief Summary
This study will assess the safety and efficacy, and the pharmacokinetics of aciclovir and valaciclovir in children with chickenpox following oral administration of valaciclovir, for the purpose of see...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Subjects aged 1 year to less than 12 years with a clinical diagnosis of chickenpox within 48 hours of the onset of the rash.
- Exclusion criteria:
- History of hypersensitivity reactions.
- Impaired hepatic or renal function.
- Gastrointestinal dysfunction.
- Serious underlying disease.
- Weigh over 40kg.
- Vaccinated for chickenpox.
Exclusion
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00169416
Start Date
March 1 2005
End Date
August 1 2005
Last Update
April 15 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.